![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Sparano J.A.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.25, Iss.5, 2002-01, pp. : 301-311
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-HER2 Cancer Therapy and Cardiotoxicity
Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
Current Drug Metabolism, Vol. 17, Iss. 1, 2016-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Palifermin: In Myelotoxic Therapy-Induced Oral Mucositis
By Siddiqui M. Asif A. Wellington Keri
Drugs, Vol. 65, Iss. 15, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)